<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81665">
  <stage>Registered</stage>
  <submitdate>26/10/2006</submitdate>
  <approvaldate>31/10/2006</approvaldate>
  <actrnumber>ACTRN12606000458538</actrnumber>
  <trial_identification>
    <studytitle>Comparison of the effects of two marketed calcium preparations on reducing serum markers of bone resorption in post menopausal women</studytitle>
    <scientifictitle>Comparison of the effects of two marketed Calcium preparations on reducing serum markers of bone resorption in post menopausal women</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Healthy volunteers (post menopausal women)</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Menstruation and menopause</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A cross over trial using Calsup (calcium carbonate) 1000 mg and Citracal (calcium citrate) 500mg given as single doses orally, one week apart following base line serum tests.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Auppression of bone resorption markers in serum</outcome>
      <timepoint>About 12 hours after each dose</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Serum calcium level</outcome>
      <timepoint>Measured as a base line before intervention and then 12 hours after each intervention.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Serum PTH (parathyroid hormone) level</outcome>
      <timepoint>Measured as a base line before intervention and then 12 hours after each intervention.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Post menopausal (menopause within last 5 years) </inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>55</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. renal failure, intake of calcium supplements, hypercalcaemiaany bone disorder.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>simple randomisation by using a randomisation table created by a computer software program</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures>subjects and assesor are blinded</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/11/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>25</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>Institute of Medical and Veterinary Science, Frome road, Adelaide, SA 5000</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Department of Clinical Biochemistry, Institute of Medical and Veterinary Science, Adelaide</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Adelaide Hospital</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Calcium supplementation has been shown to reduce the incidence of osteoporosis and related fractures. Currently Calsup (calcium carbonate) is marketed widely in Australia. This study is to compare the effects of Calsup with a newer calcium supplement, Citracal (Calcium citrate) on reducing serum markers of bone resorption. The hypothesis is that citracal may be equally effective in smaller doses and would have less side effects.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Research Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>17/10/2006</ethicapprovaldate>
      <hrec>060918</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Devika Grasby</name>
      <address>Department of Clinical Biochemistry
Institute of Medical and Veterinary Science
Frome Road
Adelaide SA 5000</address>
      <phone>+61 8 82223611</phone>
      <fax />
      <email>devika.grasby@imvs.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Devika Grasby</name>
      <address>Department of Clinical Biochemistry
Institute of Medical and Veterinary Science
Frome Road
Adelaide SA 5000</address>
      <phone>+61 8 82223611</phone>
      <fax />
      <email>devika.grasby@imvs.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>